Clinical Trial Update: Study to Assess PDM608 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating PDM608 in healthy adult subjects has been completed, with Parkinson disease listed as a condition; results were posted on 2025-11-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• PDM608

Snippet

Sponsor: Calibr, a division of Scripps Research | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-11-18